Thursday, February 15, 2007 11:47:22 PM
UPDATE 1-US Congress revives push for FDA tobacco authority
Thu Feb 15, 2007 4:40 PM ET
(Adds Altria comments in paragraphs 4, 5, 11, 12)
By Kevin Drawbaugh
WASHINGTON, Feb 15 (Reuters) - A bipartisan group of U.S. lawmakers renewed on Thursday an effort to authorize the government to regulate cigarettes as a drug, winning praise from anti-smoking forces and the maker of Marlboro cigarettes.
In a move that could reshape the tobacco industry, the lawmakers said they were introducing a bill to put cigarettes and other tobacco products for the first time clearly under the authority of the U.S. Food and Drug Administration.
The sponsors said the legislation would allow the FDA to prevent tobacco advertising targeting children; prevent sale of tobacco products to minors; reduce tobacco product toxicity; and prevent misleading claims about smoking's dangers.
Tobacco company Altria Group <MO.N>, manufacturer of the world-leading brand of Marlboro cigarettes, reaffirmed its support for giving the FDA authority over tobacco.
"We wholeheartedly support the FDA legislation introduced today in its entirety. This thoughtful legislative approach offers the best way to advance real solutions to the many complex issues involving tobacco," said company spokesman Steven Parrish in a statement.
The Senate passed legislation in 2004 to give the FDA tobacco authority, but a companion House measure died. This time, with Democrats in control on Capitol Hill, the bill could become law, said anti-smoking advocates.
"Congress has the opportunity to take a monumental step and grant the (FDA) the meaningful and long-overdue authority to regulate tobacco, which kills 440,000 people and costs our nation $96.7 billion in health care bills every year," said John Seffrin, chief executive of the American Cancer Society.
The bill was introduced in the Senate by Massachusetts Democrat Edward Kennedy and Texas Republican John Cornyn. In the House of Representatives, California Democrat Henry Waxman and Virginia Republican Tom Davis are co-sponsoring the bill.
American Heart Association Chief Executive Cass Wheeler said, "Tobacco is one of the least-regulated consumer products ... Giving FDA the authority to regulate tobacco will save countless lives and hold a renegade industry accountable."
Citing the potential for more predictability and clearer standards in the U.S. tobacco industry, Altria urged Congress to take quick action on the FDA legislation.
"The strong views and concerns expressed recently about tobacco policy highlight the growing public consensus for Congress to enact broad regulation of tobacco products." said Parrish. Altria is the parent of Philip Morris USA.
Other companies that stand to be affected include Reynolds American Inc.'s <RAI.N> R.J. Reynolds Tobacco Co., Loews Corp.'s <LTR.N> Lorillard Tobacco Co. unit and British American Tobacco Plc <BATS.L>.
Thu Feb 15, 2007 4:40 PM ET
(Adds Altria comments in paragraphs 4, 5, 11, 12)
By Kevin Drawbaugh
WASHINGTON, Feb 15 (Reuters) - A bipartisan group of U.S. lawmakers renewed on Thursday an effort to authorize the government to regulate cigarettes as a drug, winning praise from anti-smoking forces and the maker of Marlboro cigarettes.
In a move that could reshape the tobacco industry, the lawmakers said they were introducing a bill to put cigarettes and other tobacco products for the first time clearly under the authority of the U.S. Food and Drug Administration.
The sponsors said the legislation would allow the FDA to prevent tobacco advertising targeting children; prevent sale of tobacco products to minors; reduce tobacco product toxicity; and prevent misleading claims about smoking's dangers.
Tobacco company Altria Group <MO.N>, manufacturer of the world-leading brand of Marlboro cigarettes, reaffirmed its support for giving the FDA authority over tobacco.
"We wholeheartedly support the FDA legislation introduced today in its entirety. This thoughtful legislative approach offers the best way to advance real solutions to the many complex issues involving tobacco," said company spokesman Steven Parrish in a statement.
The Senate passed legislation in 2004 to give the FDA tobacco authority, but a companion House measure died. This time, with Democrats in control on Capitol Hill, the bill could become law, said anti-smoking advocates.
"Congress has the opportunity to take a monumental step and grant the (FDA) the meaningful and long-overdue authority to regulate tobacco, which kills 440,000 people and costs our nation $96.7 billion in health care bills every year," said John Seffrin, chief executive of the American Cancer Society.
The bill was introduced in the Senate by Massachusetts Democrat Edward Kennedy and Texas Republican John Cornyn. In the House of Representatives, California Democrat Henry Waxman and Virginia Republican Tom Davis are co-sponsoring the bill.
American Heart Association Chief Executive Cass Wheeler said, "Tobacco is one of the least-regulated consumer products ... Giving FDA the authority to regulate tobacco will save countless lives and hold a renegade industry accountable."
Citing the potential for more predictability and clearer standards in the U.S. tobacco industry, Altria urged Congress to take quick action on the FDA legislation.
"The strong views and concerns expressed recently about tobacco policy highlight the growing public consensus for Congress to enact broad regulation of tobacco products." said Parrish. Altria is the parent of Philip Morris USA.
Other companies that stand to be affected include Reynolds American Inc.'s <RAI.N> R.J. Reynolds Tobacco Co., Loews Corp.'s <LTR.N> Lorillard Tobacco Co. unit and British American Tobacco Plc <BATS.L>.
Recent MO News
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 04/29/2026 08:38:28 PM
- Altria Celebrates America by Investing in Our Growers, Communities, Employees and Iconic Brands • Business Wire • 04/27/2026 07:15:00 PM
- Altria to Host Webcast of 2026 First-Quarter Results • Business Wire • 04/16/2026 02:00:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/02/2026 01:02:06 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/02/2026 01:00:30 PM
- on! PLUS™ Expands Nationwide Retail Availability • Business Wire • 03/23/2026 07:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2026 06:38:41 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2026 04:10:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/02/2026 08:47:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/02/2026 08:47:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/02/2026 08:47:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/02/2026 08:47:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/02/2026 08:47:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/02/2026 08:47:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2026 06:07:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2026 06:07:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2026 06:07:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2026 06:07:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2026 06:07:16 PM
- Altria Declares Regular Quarterly Dividend of $1.06 Per Share • Business Wire • 02/26/2026 06:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/18/2026 07:30:08 PM
- Altria Presents as Part of the Consumer Analyst Group of New York Conference; Reaffirms 2026 Full-Year Earnings Guidance • Business Wire • 02/18/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/06/2026 07:55:27 PM


